نتائج البحث

Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs.

• Authors : Jones JR; The Institute of Cancer Research, London, UK. .; Brighton and Sussex Medical School, Brighton, UK. .

Subjects: Drug Resistance, Neoplasm* ; Mutation*; Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/Adaptor Proteins, Signal Transducing/*genetics

• Source: Leukemia [Leukemia] 2021 Oct; Vol. 35 (10), pp. 3017-3020. Date of Electronic Publication: 2021 Aug 09.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

The mutagenic impact of melphalan in multiple myeloma.

• Authors : Maura F; Myeloma Program, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. .; Weinhold N

Subjects: Mutagenesis* ; Mutation*; Melphalan/Melphalan/Melphalan/*adverse effects

• Source: Leukemia [Leukemia] 2021 Aug; Vol. 35 (8), pp. 2145-2150. Date of Electronic Publication: 2021 May 19.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients.

• Authors : Jones JR; NCRI Haemato-Oncology CSG

Subjects: Clonal Evolution* ; Mutation*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

• Source: Haematologica [Haematologica] 2019 Jul; Vol. 104 (7), pp. 1440-1450. Date of Electronic Publication: 2019 Feb 07.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma.

• Authors : Thomsen H; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.; Chattopadhyay S

Subjects: Genome-Wide Association Study* ; Mutation*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics

• Source: Leukemia [Leukemia] 2019 Jul; Vol. 33 (7), pp. 1817-1821. Date of Electronic Publication: 2019 Feb 08.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.

• Authors : Weinhold N; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR; and.

Subjects: Clonal Evolution* ; Genes, Tumor Suppressor* ; Mutation*

• Source: Blood [Blood] 2016 Sep 29; Vol. 128 (13), pp. 1735-44. Date of Electronic Publication: 2016 Aug 11.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Functional dissection of inherited non-coding variation influencing multiple myeloma risk.

• Authors : Ajore, R; Niroula, A; Pertesi, M ...

Subjects: B-Lymphocytes; Plasma Cells; Chromatin

تفاصيل العنوان

Genome-wide interaction and pathway-based identification of key regulators in multiple myeloma.

• Authors : Chattopadhyay, S; Thomsen, H; Yadav, P ...

Subjects: Humans; Multiple Myeloma; Disease Susceptibility

تفاصيل العنوان

Search for rare protein altering variants influencing susceptibility to multiple myeloma.

• Authors : Scales, M; Chubb, D; Dobbins, SE ...

Subjects: Humans; Multiple Myeloma; Genetic Predisposition to Disease

تفاصيل العنوان

Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries.

• Authors : Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), 1090 Jette, Belgium.; Independent Myeloma Alliance, 8808 Pfäffikon, SZ, Switzerland.

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/genetics ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/mortality

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 11; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma.

• Authors : Grab AL; Heidelberg Myeloma Center, Department of Medicine V, Medical Faculty Heidelberg and University Hospital, Heidelberg University, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/immunology

• Source: Cells [Cells] 2024 May 20; Vol. 13 (10). Date of Electronic Publication: 2024 May 20.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان